| NCT Number | NCT06701214 |
| Lead Sponsor | Vanderbilt-Ingram Cancer Center |
| Conditions | Clonal Hematopoiesis |
| Enrollment | 800 participants |
| Start Date | 2020-10-28 |
| Primary Completion | 2030-11-30 (estimated) |
| Study Completion | 2031-11-30 (estimated) |
| Updated on ClinicalTrials.gov | 2024-11-22 |